Australia, April 15 -- Roche Diagnostics Gmbh, owns the trademark (2506436) for 'LUMIRA' till Nov. 11, 2034.
Status: protected:
Registered/protected
Classes: 5 [Biological preparations for medical purposes; in vitro diagnostic preparations for medical use; diagnostic reagents for medical use; reagents for in-vitro laboratory use [for medical purposes]; diagnostic biomarker reagents for medical purposes; all the aforementioned related to infectious diseases, none related to oncological diseases and disorders.] and 10 [Testing apparatus for medical purposes; diagnostic apparatus for medical purposes; real-time polymerase chain reaction [PCR] instruments for medical use; diagnostic testing instruments for use in immunoassay procedure [medical]; immunochemical medical diagnostic testing apparatus for detecting and measuring antibody levels; apparatus for analysing substances [for medical use]; diagnostic apparatus for medical purposes used in medical laboratories; all the aforesaid related to in vitro diagnostics; none of the aforesaid related to ophthalmology.]
Type of Mark: Word
Date of Acceptance: Feb. 7
Registration Advertised: April 14
For further details contact Spruson & Ferguson and F. Hoffmann-La Roche AG .
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2506436.
Disclaimer: Curated by HT Syndication.
